News

COVID-19: Key Developments for FDA-Regulated Consumer Product Companies

April 1, 2020
Coronavirus: Multipractice Webinar

How can manufacturers and retailers of FDA-regulated consumer products address operational, regulatory, employee and charitable-marketing issues in the face of COVID-19? What should companies know? In this webinar, we discuss key developments related to essential businesses, FDA priorities and developments, tips on engaging with employees while mitigating legal risk, and considerations related to charitable giving.

To help our clients navigate the coronavirus (COVID-19) crisis, Arnold & Porter has established a Coronavirus Task Force covering a wide range of issues and challenges. Subscribe to our "Coronavirus (COVID-19)" mailing list to receive our latest client Advisories and register for upcoming webinars.

Meet the Speakers

Trenton H. Norris
Partner
Arnold & Porter
Raqiyyah Pippins
Partner
Arnold & Porter
Joshua F. Alloy
Counsel
Arnold & Porter
Bridget M. Weiss
Partner
Arnold & Porter
Subscribe
Subscribe Link

Email Disclaimer